Literature DB >> 6849773

Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.

O Brørs, G Sager, D Sandnes, S Jacobsen.   

Abstract

1 Binding of theophylline (80 mumol/l) was determined in serum from healthy subjects by equilibrium dialysis and by ultrafiltration, using [3H]-theophylline, at 22 degrees C and at different pH-values. pH was regulated by gassing with CO2 or by dialysing the serum against a phosphate buffer before use. 2 Binding of theophylline in serum was 34-38% determined by equilibrium dialysis and 41-45% determined by ultrafiltration at pH 7.4-7.5. The protein concentration in serum decreased by 12-16% during equilibrium dialysis and increased by 20% during ultrafiltration. The intersubject variation in binding was small. 3 Binding of theophylline in serum was pH-dependent with 25-30% bound at pH 7.0 and 58-60% bound at pH 8.1-8.3. Binding was significantly correlated to the fraction of ionized theophylline. 4 The binding of theophylline in normal human serum is about 35-40% at pH 7.4 and 22 degrees C. The difference in binding observed between equilibrium dialysis and ultrafiltration may be explained by the opposite changes in protein concentration during the experiment. 5 Control of pH is necessary to obtain physiologically relevant data on drug binding in serum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6849773      PMCID: PMC1427791          DOI: 10.1111/j.1365-2125.1983.tb01520.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Resin hemoperfusion as treatment for theophylline-induced seizures.

Authors:  J A Fleetham; J C Ginsburg; K Nakatsu; R D Wigle; P W Munt
Journal:  Chest       Date:  1979-06       Impact factor: 9.410

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity.

Authors:  M H Jacobs; R M Senior; G Kessler
Journal:  JAMA       Date:  1976-05-03       Impact factor: 56.272

4.  Relationship between theophylline concentration in plasma and saliva of man.

Authors:  R Koysooko; E F Ellis; G Levy
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

5.  Theophylline-induced seizures in adults. Correlation with serum concentrations.

Authors:  C W Zwillich; F D Sutton; T A Neff; W M Cohn; R A Matthay; M M Weinberger
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

6.  Theophylline disposition in patients with hepatic cirrhosis.

Authors:  K M Piafsky; D S Sitar; R E Rangno; R I Ogilvie
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

7.  Pharmacokinetics of theophylline in hepatic disease.

Authors:  A Mangione; T E Imhoff; R V Lee; L Y Shum; W J Jusko
Journal:  Chest       Date:  1978-05       Impact factor: 9.410

8.  Theophylline protein binding in humans.

Authors:  K J Simons; F E Simons; C J Briggs; L Lo
Journal:  J Pharm Sci       Date:  1979-02       Impact factor: 3.534

9.  The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence, and equilibrium dialysis.

Authors:  J Wilting; W F van der Giesen; L H Janssen; M M Weideman; M Otagiri; J H Perrin
Journal:  J Biol Chem       Date:  1980-04-10       Impact factor: 5.157

10.  Comparative pharmacokinetics of theophylline and aminophylline in man.

Authors:  A Aslaksen; O M Bakke; T Vigander
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

View more
  8 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver.

Authors:  Barent DuBois; Samantha Louey; George D Giraud; Ganesh Cherala; Sonnet S Jonker
Journal:  Basic Clin Pharmacol Toxicol       Date:  2015-03-19       Impact factor: 4.080

3.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

4.  pH lability in serum during equilibrium dialysis.

Authors:  O Brørs; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

5.  Binding of pyrimethamine to human plasma proteins and erythrocytes.

Authors:  A C Rudy; W J Poynor
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

6.  The protein binding of timegadine determined by equilibrium dialysis.

Authors:  S George; A McBurney; J Ward
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

7.  Free and total plasma theophylline concentrations in chronic airflow obstruction.

Authors:  P Ebden; D Leopold; A P Smith; D Buss; P A Routledge
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

8.  Simple, fast and reliable liquid chromatographic and spectrophotometric methods for the determination of theophylline in urine, saliva and plasma samples.

Authors:  Mohammad Charehsaz; Aylin Gürbay; Ahmet Aydin; Gönül Sahin
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.